Pfizer will study the effectiveness of its vaccine against COVID-19 by inoculating the whole population over the age of 12 in a town in southern Brazil, the company said on Wednesday.
The study will be conducted in Toledo, population 143,000, in the west of Parana state, together with Brazil's National Vaccination Program, local health authorities, a hospital and the federal university.
Pfizer said the purpose was to study the behaviour of COVID-19 in a "real life scenario" after the population has been vaccinated.
"The initiative is the first and only of its kind to be undertaken in a developing country in collaboration with the pharmaceutical company," it added.
8 Indonesian airports remain shut due to volcanic ash from Anak Krakatau
US peace envoys meet Zelenskyy in Kyiv after Putin talks
US targets three Iranian oil vessels after attack on Navy ships
Israeli strikes kill seven in southern Lebanon
Indonesia's Anak Krakatau eruption halts flights, schools, fishing
Putin says US-Russia contacts beneficial as talks begin with Witkoff and Kushner
Chinese national rescued from Nepal tunnel 10 days after flash flood
US envoys Witkoff, Kushner arrive in Moscow for talks on peace in Ukraine
